HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gerhard Steinbeck Selected Research

1-(9-fluorenyl)ethyl chloroformate

6/2017Predictors of sinus rhythm after electrical cardioversion of atrial fibrillation: results from a data mining project on the Flec-SL trial data set.
10/2013Low stroke risk after elective cardioversion of atrial fibrillation: an analysis of the Flec-SL trial.
7/2012Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial.
11/2005Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gerhard Steinbeck Research Topics

Disease

17Myocardial Infarction
07/2016 - 05/2004
14Atrial Fibrillation
12/2018 - 07/2003
9Heart Failure
01/2016 - 07/2003
8Ventricular Tachycardia
01/2013 - 12/2002
7Stroke (Strokes)
10/2022 - 03/2004
7Pathologic Constriction (Stenosis)
12/2012 - 05/2004
6Cardiac Sudden Death (Sudden Cardiac Arrest)
11/2010 - 12/2002
6Tachycardia (Tachyarrhythmias)
08/2007 - 01/2002
4Heart Diseases (Heart Disease)
01/2022 - 08/2007
4Cardiomyopathies (Cardiomyopathy)
03/2014 - 05/2004
4Torsades de Pointes (Torsade de Pointes)
01/2013 - 04/2003
4Long QT Syndrome
02/2012 - 04/2003
3Infarction (Infarctions)
10/2013 - 08/2007
3Aneurysm (Aneurysms)
12/2012 - 06/2003
3Acute Coronary Syndrome
10/2010 - 03/2004
3ST Elevation Myocardial Infarction
10/2010 - 10/2006
2Hemorrhage
10/2022 - 10/2013
2Body Weight (Weight, Body)
03/2014 - 10/2010
2Atrioventricular Block
02/2014 - 04/2009
2Ischemia
06/2008 - 07/2004
2Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
05/2004 - 07/2003
1Embolism (Embolus)
10/2022
1Atrial Flutter (Flutter, Atrial)
12/2018
1Cardiogenic Shock
04/2014
1Right Ventricular Dysfunction
03/2014
1Transient Ischemic Attack
10/2013
1Lung Diseases (Lung Disease)
08/2013
1Coronary Stenosis (Coronary Artery Stenosis)
12/2012
1Peripheral Vascular Diseases (Peripheral Vascular Disease)
09/2012
1Aortic Valve Stenosis (Aortic Stenosis)
09/2012
1Chronic Renal Insufficiency
09/2012
1Acute Kidney Injury (Acute Renal Failure)
09/2012
1Systemic Scleroderma (Systemic Sclerosis)
07/2012
1Drug-Related Side Effects and Adverse Reactions
02/2012
1Cognitive Dysfunction
12/2009
1Atherosclerosis
09/2009
1Rupture
09/2009
1Thrombosis (Thrombus)
08/2009
1Bites and Stings (Sting)
08/2009
1Myocardial Ischemia (Ischemic Heart Diseases)
08/2009
1Anaphylaxis (Anaphylactic Shock)
08/2009
1Unstable Angina
01/2008
1Cardiac Arrhythmias (Arrythmia)
01/2008

Drug/Important Bio-Agent (IBA)

8Granulocyte Colony-Stimulating Factor (G-CSF)IBA
07/2016 - 10/2006
7Pharmaceutical PreparationsIBA
01/2013 - 01/2002
6Anti-Arrhythmia AgentsIBA
11/2013 - 11/2005
41-(9-fluorenyl)ethyl chloroformateIBA
06/2017 - 11/2005
3AnticoagulantsIBA
12/2020 - 01/2012
3Sitagliptin Phosphate (Januvia)FDA Link
07/2016 - 11/2010
3Dipeptidyl-Peptidase IV InhibitorsIBA
02/2016 - 11/2010
3Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
11/2013 - 10/2006
3CalciumIBA
12/2012 - 05/2004
2Vitamin KFDA Link
10/2022 - 08/2015
2Flecainide (Tambocor)FDA LinkGeneric
06/2017 - 11/2005
2Olmesartan Medoxomil (Votum)FDA Link
02/2012 - 01/2007
2Angiotensin IIIBA
02/2012 - 01/2007
2OligonucleotidesIBA
06/2008 - 05/2004
2CytokinesIBA
06/2008 - 06/2008
2Sotalol (Sotalol Hydrochloride)FDA LinkGeneric
12/2007 - 04/2003
2Adenosine (Adenocard)FDA LinkGeneric
08/2007 - 08/2004
2Biomarkers (Surrogate Marker)IBA
10/2006 - 08/2002
2Messenger RNA (mRNA)IBA
05/2005 - 05/2004
1Simendan (Levosimendan)IBA
03/2014
1Eicosapentaenoic AcidIBA
11/2013
1Docosahexaenoic AcidsIBA
11/2013
1Antidepressive Agents (Antidepressants)IBA
11/2013
1Hypoglycemic Agents (Hypoglycemics)IBA
10/2013
1Phenobarbital (Luminal)FDA Link
12/2012
1Angiotensin Receptors (Angiotensin II Receptor)IBA
02/2012
1olmesartanIBA
02/2012
1Potassium Channels (Potassium Channel)IBA
02/2012
1Filgrastim (Neupogen)FDA Link
10/2010
1EnzymesIBA
09/2009
1Matrix Metalloproteinases (MMPs)IBA
09/2009
1LipidsIBA
09/2009
1Sirolimus (Rapamycin)FDA Link
08/2009
1Arthropod VenomsIBA
08/2009
1Chemokine CXCL12IBA
04/2009
1Complementary DNA (cDNA)IBA
06/2008
1A-factor (Streptomyces)IBA
01/2008

Therapy/Procedure

20Therapeutics
07/2016 - 03/2004
9Catheter Ablation
12/2018 - 01/2002
5Heart Transplantation (Grafting, Heart)
07/2012 - 08/2007
5Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
10/2009 - 07/2003
4Electric Countershock (Cardioversion)
06/2017 - 11/2005
4Hematopoietic Stem Cell Mobilization
10/2013 - 10/2006
3Catheters
12/2020 - 01/2002
3Percutaneous Coronary Intervention
10/2010 - 10/2006
3Defibrillators (Defibrillator)
07/2010 - 06/2009
3Stents
08/2009 - 06/2004
2Transcatheter Aortic Valve Replacement
02/2014 - 09/2012
2Bioprosthesis
08/2013 - 12/2012
2Blood Transfusion (Blood Transfusions)
12/2012 - 09/2012
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
10/2010 - 06/2004
1Length of Stay
01/2022
1Contraindications
08/2015
1Surgical Instruments (Clip)
04/2014
1Extracorporeal Membrane Oxygenation
03/2014
1Renal Replacement Therapy (Therapies, Renal Replacement)
09/2012
1Duration of Therapy
04/2009